Mendeley Supplementary Table 1: 48 hour improvement in itch response for FDA-approved drugs for AD and/or PN

Mendeley Supplementary Table 1: 48 hour improvement in itch response for FDA-approved drugs for AD and/or PN曼德利（Mendeley）补充表1：美国食品药品监督管理局（Food and Drug Administration, FDA）批准的用于特应性皮炎（Atopic Dermatitis, AD）和/或结节性痒疹（Prurigo Nodularis, PN）的药物的48小时瘙痒应答改善情况